FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2141570886> ?p ?o ?g. }

• W2141570886 endingPage "1611" @default.
• W2141570886 startingPage "1604" @default.
• W2141570886 abstract "We evaluated the chemical and enzymatic stabilities of prodrugs containing methoxy, ethoxy and propylene glycol linkers in order to find a suitable linker for prodrugs of carboxylic acids with amino acids. l-Valine and l-phenylalanine prodrugs of model compounds (benzoic acid and phenyl acetic acid) containing methoxy, ethoxy and propylene glycol linkers were synthesized. The hydrolysis rate profile of each compound was studied at physiologically relevant pHs (1.2, 4, 6 and 7.4). Enzymatic hydrolysis of propylene glycol containing compounds was studied using Caco-2 homogenate as well as purified enzyme valacyclovirase. It was observed that the stability of the prodrugs increases with the linker length (propyl > ethyl > methyl). The model prodrugs were stable at acidic pH as compared to basic pH. It was observed that the prodrug with the aliphatic amino acid promoiety was more stable compared to its aromatic counterpart. The comparison between benzyl and the phenyl model compounds revealed that the amino acid side chain is significant in determining the stability of the prodrug whereas the benzyl or phenyl carboxylic acid had little or no effect on the stability. The enzymatic activation studies of propylene glycol linker prodrug in the presence of valacyclovirase and cell homogenate showed faster generation of the parent drug at pH 7.4. The half-life of prodrugs at pH 7.4 was more than 12 h, whereas in the presence of cell homogenate the half-lives were less than 1 h. Hydrolysis by Caco-2 homogenate generated the parent compound in two steps, where the prodrug was first converted to the intermediate, propylene glycol benzoate, which was then converted to the parent compound (benzoic acid). Enzymatic hydrolysis of propylene glycol containing prodrugs by valacyclovirase showed hydrolysis of the amino acid ester part to generate the propylene glycol ester of model compound (propylene glycol benzoate) as the major product. The amino acid prodrugs containing methoxy linker were the least stable while prodrugs containing propylene glycol linker were most stable. This work suggests that the propylene glycol linker is an optimal linker for amino acid prodrugs since it has good chemical stability and is enzymatically hydrolyzed to yield the parent drug. This approach can be further extended to other non-amino acid prodrugs and to provide a chemical handle to modify lead molecules containing carboxylic group(s)." @default.
• W2141570886 created "2016-06-24" @default.
• W2141570886 creator A5015322651 @default.
• W2141570886 creator A5028004042 @default.
• W2141570886 creator A5037047234 @default.
• W2141570886 creator A5085453188 @default.
• W2141570886 date "2009-07-20" @default.
• W2141570886 modified "2023-09-23" @default.
• W2141570886 title "Chemical and Enzymatic Stability of Amino Acid Prodrugs Containing Methoxy, Ethoxy and Propylene Glycol Linkers" @default.
• W2141570886 cites W1486888545 @default.
• W2141570886 cites W1559370499 @default.
• W2141570886 cites W1560224791 @default.
• W2141570886 cites W1978211222 @default.
• W2141570886 cites W1985382224 @default.
• W2141570886 cites W2023983069 @default.
• W2141570886 cites W2031422459 @default.
• W2141570886 cites W2032004441 @default.
• W2141570886 cites W2061241623 @default.
• W2141570886 cites W2072131452 @default.
• W2141570886 cites W2073161317 @default.
• W2141570886 cites W2073711060 @default.
• W2141570886 cites W2074419543 @default.
• W2141570886 cites W2107877455 @default.
• W2141570886 cites W2110387631 @default.
• W2141570886 cites W2132811836 @default.
• W2141570886 cites W2137631620 @default.
• W2141570886 cites W2150535357 @default.
• W2141570886 cites W2158379228 @default.
• W2141570886 cites W2176091001 @default.
• W2141570886 cites W2951568508 @default.
• W2141570886 cites W4232469224 @default.
• W2141570886 cites W4234944446 @default.
• W2141570886 doi "https://doi.org/10.1021/mp900084v" @default.
• W2141570886 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3496387" @default.
• W2141570886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19566080" @default.
• W2141570886 hasPublicationYear "2009" @default.
• W2141570886 type Work @default.
• W2141570886 sameAs 2141570886 @default.
• W2141570886 citedByCount "35" @default.
• W2141570886 countsByYear W21415708862012 @default.
• W2141570886 countsByYear W21415708862013 @default.
• W2141570886 countsByYear W21415708862014 @default.
• W2141570886 countsByYear W21415708862015 @default.
• W2141570886 countsByYear W21415708862016 @default.
• W2141570886 countsByYear W21415708862017 @default.
• W2141570886 countsByYear W21415708862018 @default.
• W2141570886 countsByYear W21415708862019 @default.
• W2141570886 countsByYear W21415708862020 @default.
• W2141570886 countsByYear W21415708862021 @default.
• W2141570886 countsByYear W21415708862022 @default.
• W2141570886 countsByYear W21415708862023 @default.
• W2141570886 crossrefType "journal-article" @default.
• W2141570886 hasAuthorship W2141570886A5015322651 @default.
• W2141570886 hasAuthorship W2141570886A5028004042 @default.
• W2141570886 hasAuthorship W2141570886A5037047234 @default.
• W2141570886 hasAuthorship W2141570886A5085453188 @default.
• W2141570886 hasBestOaLocation W21415708862 @default.
• W2141570886 hasConcept C108215921 @default.
• W2141570886 hasConcept C111919701 @default.
• W2141570886 hasConcept C178790620 @default.
• W2141570886 hasConcept C181199279 @default.
• W2141570886 hasConcept C185592680 @default.
• W2141570886 hasConcept C2778844314 @default.
• W2141570886 hasConcept C2780263894 @default.
• W2141570886 hasConcept C2780557392 @default.
• W2141570886 hasConcept C41008148 @default.
• W2141570886 hasConcept C515207424 @default.
• W2141570886 hasConcept C55493867 @default.
• W2141570886 hasConcept C71240020 @default.
• W2141570886 hasConcept C90150868 @default.
• W2141570886 hasConcept C94412978 @default.
• W2141570886 hasConceptScore W2141570886C108215921 @default.
• W2141570886 hasConceptScore W2141570886C111919701 @default.
• W2141570886 hasConceptScore W2141570886C178790620 @default.
• W2141570886 hasConceptScore W2141570886C181199279 @default.
• W2141570886 hasConceptScore W2141570886C185592680 @default.
• W2141570886 hasConceptScore W2141570886C2778844314 @default.
• W2141570886 hasConceptScore W2141570886C2780263894 @default.
• W2141570886 hasConceptScore W2141570886C2780557392 @default.
• W2141570886 hasConceptScore W2141570886C41008148 @default.
• W2141570886 hasConceptScore W2141570886C515207424 @default.
• W2141570886 hasConceptScore W2141570886C55493867 @default.
• W2141570886 hasConceptScore W2141570886C71240020 @default.
• W2141570886 hasConceptScore W2141570886C90150868 @default.
• W2141570886 hasConceptScore W2141570886C94412978 @default.
• W2141570886 hasIssue "5" @default.
• W2141570886 hasLocation W21415708861 @default.
• W2141570886 hasLocation W21415708862 @default.
• W2141570886 hasLocation W21415708863 @default.
• W2141570886 hasOpenAccess W2141570886 @default.
• W2141570886 hasPrimaryLocation W21415708861 @default.
• W2141570886 hasRelatedWork W1601409520 @default.
• W2141570886 hasRelatedWork W1989103160 @default.
• W2141570886 hasRelatedWork W2007074695 @default.
• W2141570886 hasRelatedWork W2027790609 @default.
• W2141570886 hasRelatedWork W2069913866 @default.
• W2141570886 hasRelatedWork W2091353596 @default.
• W2141570886 hasRelatedWork W2095581038 @default.

• next